Whitehawk Therapeutics Inc Sustainability Reports
Whitehawk Therapeutics, Inc. is a clinical-stage oncology biotechnology company that develops next-generation antibody-drug conjugates (ADCs) for cancer treatment.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300G3U7TKW1M58L09
FIGI: BBG002WN7DV9
1 reports from 2024 to 2024